MFC Co Ltd
KOSDAQ:432980
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
M
|
MFC Co Ltd
KOSDAQ:432980
|
KR |
|
Pininfarina SpA
MIL:PINF
|
IT |
|
Landmark REIT
SGX:D5IU
|
SG |
|
PhosAgro PAO
MOEX:PHOR
|
RU |
|
Covivio SA
OTC:GSEFF
|
FR |
|
Blue Bird Corp
F:4RB
|
US |
|
S
|
Sumitomo Realty & Development Co Ltd
DUS:RL2
|
JP |
|
G
|
Gen Digital Inc
F:SYM
|
US |
|
A
|
argenx SE
SWB:1AE
|
NL |
|
Cousins Properties Inc
F:CPZ1
|
US |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de MFC Co Ltd.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace MFC
MFC Co., Ltd. is a pharmaceutical company that engages in pharmaceutical research and development, API''s, pharmaceutical intermediaries, Pd catalyst, and custom manufacturing services. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 65 full-time employees. The company went IPO on 2024-12-26. The firm operates its business through two segments. The Active Pharmaceutical Ingredient (API) and Key Material segment is mainly engaged in the development and production of APIs for generic drugs and related key intermediate materials.
- Sede central
- Corea KR
- Empleados
- 65
- Fecha de salida a bolsa
- 26 dic., 2024
